loading
전일 마감가:
$2.74
열려 있는:
$2.85
하루 거래량:
648.91K
Relative Volume:
5.45
시가총액:
$104.84M
수익:
$1.50M
순이익/손실:
$-81.41M
주가수익비율:
-0.467
EPS:
-6.51
순현금흐름:
$-43.75M
1주 성능:
+9.31%
1개월 성능:
+23.80%
6개월 성능:
+39.48%
1년 성능:
+96.34%
1일 변동 폭
Value
$2.78
$3.3599
1주일 범위:
Value
$2.66
$3.3599
52주 변동 폭
Value
$1.235
$5.00

립 테라퓨틱스 Stock (LPTX) Company Profile

Name
명칭
Leap Therapeutics Inc
Name
전화
617 252 4343
Name
주소
47 THORNDIKE STREET, CAMBRIDGE, MA
Name
직원
54
Name
트위터
@LeapTherapeutic
Name
다음 수익 날짜
2024-08-12
Name
최신 SEC 제출 서류
Name
LPTX's Discussions on Twitter

립 테라퓨틱스 Stock (LPTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-10-04 개시 Mizuho Buy
2021-06-04 재개 Robert W. Baird Outperform
2020-06-29 개시 Piper Sandler Overweight
2020-02-11 개시 Robert W. Baird Outperform
2019-11-15 다운그레이드 Raymond James Outperform → Mkt Perform
2019-09-13 재개 Raymond James Outperform
2017-03-07 개시 Ladenburg Thalmann Buy
모두보기

립 테라퓨틱스 주식(LPTX)의 최신 뉴스

pulisher
Sep 10, 2024

Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story - Simply Wall St

Sep 10, 2024
pulisher
Sep 05, 2024

Vera Therapeutics (NASDAQ:VERA) vs. Pivotal Therapeutics (OTCMKTS:PVTTF) Financial Analysis - Defense World

Sep 05, 2024
pulisher
Sep 03, 2024

Global Gastric Cancer Diagnostics Market is Expected to Expand at a CAGR of ~7% by 2030 | DelveInsight - PR Newswire UK

Sep 03, 2024
pulisher
Sep 02, 2024

Lululemon Athletica (NASDAQ:LULU) Price Target Lowered to $326.00 at Morgan Stanley - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.20 Million Stake in Paychex, Inc. (NASDAQ:PAYX) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Laramide Resources Ltd. (TSE:LAM) Director Buys C$10,200.00 in Stock - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Buys Shares of 8,904 Capital Group Growth ETF (NYSEARCA:CGGR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Picton Mahoney Asset Management Takes $71,000 Position in American Woodmark Co. (NASDAQ:AMWD) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Makes New Investment in iShares Core MSCI Europe ETF (NYSEARCA:IEUR) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Farther Finance Advisors LLC Has $1.36 Million Stake in McKesson Co. (NYSE:MCK) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Intel Co. (NASDAQ:INTC) Shares Purchased by Farther Finance Advisors LLC - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Takes Position in BlackRock MuniHoldings Quality Fund II, Inc. (NYSE:MUE) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Trims Stock Holdings in Universal Health Services, Inc. (NYSE:UHS) - Defense World

Sep 02, 2024
pulisher
Sep 02, 2024

Allspring Global Investments Holdings LLC Sells 103,605 Shares of Wabash National Co. (NYSE:WNC) - Defense World

Sep 02, 2024
pulisher
Aug 31, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update - MarketBeat

Aug 31, 2024
pulisher
Aug 27, 2024

Sermonix Pharmaceuticals Completes Enrollment of Phase 2 - GlobeNewswire

Aug 27, 2024
pulisher
Aug 22, 2024

Atossa and Quantum Leap dose first subject in breast cancer therapy trial - Yahoo Finance

Aug 22, 2024
pulisher
Aug 21, 2024

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer - ForexTV.com

Aug 21, 2024
pulisher
Aug 21, 2024

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer - Yahoo Finance

Aug 21, 2024
pulisher
Aug 21, 2024

Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer - StockTitan

Aug 21, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Buys 457,904 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

AstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average of $11,535.34 - Defense World

Aug 20, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Acquires 156,044 Shares of Priority Technology Holdings, Inc. (NASDAQ:PRTH) - Defense World

Aug 20, 2024
pulisher
Aug 19, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Sees Large Decline in Short Interest - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Leap Therapeutics, Inc. (NASDAQ:LPTX) Sees Large Decline in Short Interest - Defense World

Aug 19, 2024
pulisher
Aug 15, 2024

Analysts Issue Forecasts for Leap Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:LPTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

Q3 2024 EPS Estimates for MiNK Therapeutics, Inc. (NASDAQ:INKT) Boosted by Analyst - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

HLS Therapeutics Inc. (TSE:HLS) to Post Q3 2024 Earnings of ($0.19) Per Share, Stifel Canada Forecasts - Defense World

Aug 15, 2024
pulisher
Aug 13, 2024

Leap Therapeutics (NASDAQ:LPTX) Given Buy Rating at HC Wainwright - MarketBeat

Aug 13, 2024
pulisher
Aug 13, 2024

Leap Therapeutics’ (LPTX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Aug 13, 2024
pulisher
Aug 12, 2024

LPTX Stock Earnings: Leap Therapeutics Misses EPS for Q2 2024 - InvestorPlace

Aug 12, 2024
pulisher
Aug 12, 2024

Leap Therapeutics Reports Second Quarter 2024 Financial Results - citybiz

Aug 12, 2024
pulisher
Aug 12, 2024

Orphan Drugs and Rare Diseases Conference (Boston, MA, United StatesOctober 17-18, 2024)Navigating Orphan Drugs & Rare Diseases from Regulation to Detection & Precision TreatmentsResearchAndMarkets.com - Manchestertimes

Aug 12, 2024
pulisher
Aug 12, 2024

Leap Therapeutics Reports Second Quarter 2024 Financial Results - PR Newswire

Aug 12, 2024
pulisher
Aug 09, 2024

Venous Leg Ulcers Treatment Industry Size, Innovations Driving Industry Evolution (2024-2035) - அக்னி செய்திகள்

Aug 09, 2024
pulisher
Aug 04, 2024

Travere Therapeutics (NASDAQ:TVTX) PT Raised to $14.00 at Barclays - Defense World

Aug 04, 2024
pulisher
Jul 30, 2024

Global Venous Leg Ulcers Treatment Market 2024 Analysis by Top Key Players |MediWound Ltd, NovaLead Pharma Pvt Ltd - The NRI News

Jul 30, 2024
pulisher
Jul 29, 2024

Tivic Health Systems Inc. (NASDAQ: TIVC): A Promising Leap with New Patents and Market Performance - BP Journal

Jul 29, 2024
pulisher
Jul 27, 2024

Acadian Asset Management LLC Has $750,000 Stock Position in Leap Therapeutics, Inc. (NASDAQ:LPTX) - Defense World

Jul 27, 2024
pulisher
Jul 23, 2024

Leap and Samsung SmartThings Deploy Automated Virtual Power Plant Solutions - Yahoo Finance

Jul 23, 2024
pulisher
Jul 19, 2024

EASA Certifies LEAP-powered Airbus A321XLR - Yahoo Finance

Jul 19, 2024
pulisher
Jul 18, 2024

Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers - PRIME® Continuing Medical Education

Jul 18, 2024
pulisher
Jul 18, 2024

Taking the Leap: Moving From Large to Small Biopharmas - BioSpace

Jul 18, 2024
pulisher
Jul 16, 2024

Leap Health Announces Partnership with Covet Health to Reduce Specialty Drug Costs and Improve Patient Outcomes - Yahoo Finance

Jul 16, 2024
pulisher
Jul 15, 2024

LEAP Introduces AI Innovations to Drive the Future of the Legal Profession - Yahoo Finance

Jul 15, 2024
pulisher
Jul 14, 2024

Allspring Global Investments Holdings LLC Invests $34,000 in Advance Auto Parts, Inc. (NYSE:AAP) - Defense World

Jul 14, 2024
pulisher
Jul 14, 2024

Short Interest in Leap Therapeutics, Inc. (NASDAQ:LPTX) Drops By 14.5% - MarketBeat

Jul 14, 2024
pulisher
Jul 14, 2024

Short Interest in Mama’s Creations, Inc. (NASDAQ:MAMA) Drops By 14.2% - Defense World

Jul 14, 2024
pulisher
Jul 14, 2024

Allspring Global Investments Holdings LLC Acquires New Shares in Hess Midstream LP (NYSE:HESM) - Defense World

Jul 14, 2024
pulisher
Jul 14, 2024

Twilio Inc. (NYSE:TWLO) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Jul 14, 2024
pulisher
Jul 14, 2024

Sumitomo Mitsui Trust Holdings Inc. Acquires Shares of 10,370 Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) - Defense World

Jul 14, 2024

립 테라퓨틱스 (LPTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$26.56
price down icon 1.26%
$196.11
price down icon 1.22%
$28.98
price down icon 9.71%
$69.58
price up icon 1.94%
$127.27
price up icon 3.16%
$538.98
price up icon 0.25%
자본화:     |  볼륨(24시간):